Opiant Pharmaceuticals, Inc. carries a market capitalization of 108.80M, placing it among publicly traded companies globally.
| Market Cap | 108.80M |
| Enterprise Value | N/A |
Opiant Pharmaceuticals, Inc.'s stock has declined approximately -3.59477% over the past 52 weeks. The 50-day moving average sits at 20.50, while the 200-day moving average is 14.79.
| Beta (5Y) | N/A |
| 52-Week Price Change | -3.59477% |
| 50-Day Moving Average | 20.50 |
| 200-Day Moving Average | 14.79 |
| Average Volume (20 Days) | N/A |
Opiant Pharmaceuticals, Inc.'s most recent stock split took place on December 31, 2014 with a 100:1 split ratio.
| Last Split Date | 12/31/2014 |
| Split Ratio | 100:1 |